Real-World Treatment Patterns and Progression-Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+Non-Small Cell Lung Cancer..

Written by

Lin Huamao M, Pan Xiaoyun, Yin Yu, Wu Yanyu, Nordstrom Beth, Socinski Mark A

Journal: The oncologist , volume: June; 3